Trial Profile
Comparison of duration of treatment of metformin + sitagliptin versus metformin + sulfonylurea in real-world patients with Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2015
Price :
$35
*
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Mar 2015 New trial record